तुलना करने के लिए मीट्रिक्स | 300676 | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंध300676पीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | −24.6x | −14.5x | −0.4x | |
PEG अनुपात | −0.65 | −0.19 | 0.00 | |
क़ीमत/बुक | 1.7x | 2.3x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 3.7x | 10.4x | 3.1x | |
अपसाइड (विश्लेषक लक्ष्य) | 38.7% | 20.4% | 48.9% | |
उचित मूल्य अपसाइड | अनलॉक करें | 10.9% | 6.8% | अनलॉक करें |
BGI Genomics Co., Ltd. engages in the provision of genomic sequencing services and proteomic services to academic institutions, pharmaceutical companies, health care providers and other organizations in China and internationally. The company offers DNA sequencing services covering whole genome sequencing, plant/animal whole genome sequencing, exome sequencing, de novo sequencing, and metagenomic sequencing; and mass spectrometry services, such as proteomic services and biologics characterization services. It also provides diagnostics and precision medicine, such as COVID-19 solutions, partnership opportunities, infectious diseases, and oncology services. The company was formerly known as Shenzhen BGI Medicine Co., Ltd. and changed its name to BGI Genomics Co., Ltd. in 2015. The company was founded in 1999 and is headquartered in Shenzhen, China. BGI Genomics Co., Ltd. operates as a subsidiary of BGI Group.